Supplement manufacturer Biohm Health has announced a $7.5 million cash infusion that the company says will help it to further develop the use of artificial intelligence in its product formulations.
Omaha-based supplement marketer FitLife Brands has reported promising full year revenue that comes with a serious caveat in that the company may need to restate its financial results going back to its 2019 fiscal year.
The French government's financing initiative has approved Seventure’s Health for Life Capital fund meaning investors will devote over €5 billion to innovative companies in the field of the microbiome before the end of 2022.
In an effort to promote innovation, Rabobank announces launch of the Rabo Food & Agri Innovation Fund (RFAIF), allowing companies to receive up to €3 million.
A hangover from the negative publicity of the past year has stalled M&A and financing activity in dietary supplements, even as this activity booms in other categories of the health and wellness space, according to investment group Nutrition Capital...
On the back of a deal with a ‘strong’ equity partner, Barentz International will use the additional funds to accelerate growth in its key markets in Europe, India, China and Asia Pacific, it said.
The inclusion of new voluntary best practices in the organisation’s revised trader standard is an “interesting” element, said a representative at Voice Network.
Danone shares rose today as rumours strengthened the French dairy giant would sell its medical and paediatric nutrition business (Nutricia), but is the firm streamlining its activities around its core foods businesses or just shifting infant-medical...
Nutrition Capital Network noted a record 247 deals in the health and wellness sector in 2012. Within that number, the group noted a decline in the number of M&A deals from the previous year, but an increase in financings.
Neptune Technologies and Bioressources has announced a plan to recover from an explosion and fire at its processing plant in Sherbrooke, Quebec that put a halt to production of the company’s krill oil products.
Croatian food company Atlantic Grupa has won a €307m finance package from the European Bank for Reconstruction and Development (EBRD) for new energy systems, sustainability certifications and working capital financing.
Management at embattled resveratrol supplier Fluxome has come in for severe criticism as the company hovers on the verge of financial collapse unless a fresh investor can be found in the coming weeks.
Provexis has secured over £2m in extra funding to pursue acquisitions as it looks to build on its positive health claim opinion for FruitFlow technology.
KGK Synergize has a full pipeline of new nutraceutical products,
and is seeking additional growth capital of between C$7 and $10m to
bring them to market over the coming years.
UK dosage form specialist BioProgress gave the first insight into
its much-anticipated strategic review yesterday, just over a month
after the departure of former CEO Graham Hind, reports Phil
Taylor.
Up-and-coming Advanced Bionutrition (ABN) has captured the
attention of venture capitalists in the biotechnology field,
raising $7.5 million in a second round of private equity funding.
Leiner Health Products, a leading manufacturer of store brand
vitamins, minerals, and nutritional supplements, has seen a solid
financial performance in the first quarter of fiscal 2005 as its
new capital structure came into play.
Dutch group Numico, now focusing on babyfood and clinical
nutrition, has the potential to be among the fastest growing
companies in consumer staples, say analysts at Goldman Sachs.
Swiss speciality chemicals group Lonza announced yesterday that it
was to restructure two business sectors, resulting in the loss of
225 jobs or 3 per cent of its 6,400 workforce.
Vanson HaloSource, the US company which specialises in
chitosan-based products, has completed a new round of financing
which will help it finance the development of new supplement
products.
Vital Living sucessfully completes private placement, raising more
than $3m, but Herbalife finds there is little interest in its bond
issue from European investors.
